ArticleJournal of thoracic disease2024

Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study.

Jiazhuo Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.